Background: Pulmonary hypertension (PH) is very prevalent among heart failure (HF) subjects and is now recognised as an independent predictor of poor prognosis. There is a paucity of data in our environment about the frequency and correlates of PH in HF. We aimed to determine the frequency of PH in HF patients in an academic hospital and assess its correlates using echocardiography. Methods: A total of 219 heart failure patients in NYHA functional class II to IV, and without co-morbidities that could cause PH, were consecutively recruited. Demographic, clinical and echocardiographic data were obtained from all subjects. Results: The frequency of PH was 38.8%, using an estimated pulmonary artery systolic pressure (PASP) cut-off value of > 36 mmHg. HF subjects with PH tended to be male with a worse NYHA functional class compared with subjects without PH. HF subjects with PH also had significantly higher left ventricular (LV) filling pressures (higher left atrial volume index and E/e′ ratio), more severe mitral regurgitation (MR), poorer LV systolic function, and worse parameters of right ventricular (RV) structure and function compared with those without PH. Echocardiographic variables that correlated significantly with PASP include LV filling pressures (p < 0.001 for all), mitral regurgitant volume (r = 0.269, p < 0.001) and LV ejection fraction (r = -0.239, p > 0.001). On multivariate analysis, the left atrial volume index and E/e′ ratio were independently associated with PASP. Conclusion: PH is common among HF subjects in our environment and is associated with higher LV filling pressure, more severe MR, poorer LV systolic function and worse RV remodelling. Routine screening for PH among HF patients is recommended for better risk stratification and management.
Pulmonary hypertension (PH) is very prevalent among heart failure (HF) subjects and is now recognised as an independent predictor of poor prognosis.
1,2 PH develops initially from passive congestion of the pulmonary venous circulation, secondary to elevated filling pressures of the left cardiac chambers. Later, functional and structural changes may occur in the pulmonary venous and distal arterial circulation, resulting in a fixed or reactive form of PH. 3 The key correlates of PH in HF are factors associated with increased pulmonary venous pressure. 4 These include elevated left ventricular (LV) filling pressures and mitral regurgitation (MR), which have been demonstrated by several studies. 1, 2, [5] [6] [7] The role of other factors, such as clinical parameters and LV systolic function is less clear. Right heart catheterisation is the goldstandard method for making a definitive diagnosis in selected patients. 8, 9 Echocardiography is a convenient, non-invasive investigation widely used in clinical practice to screen for PH, as suggested by the guidelines. 8, 9 Not much is known presently about the frequency and correlates of PH in HF in our environment. We therefore evaluated the frequency of PH in an academic hospital in southwestern Nigeria, and its correlates using echocardiography. It is expected that results from this study will help improve risk stratification, management and prognostication in our patients with HF.
Methods
This was a cross-sectional study carried out at the Lagos University Teaching Hospital in south-western Nigeria. We consecutively recruited 219 HF patients of 18 years or older, who were in New York Heart Association (NYHA) functional class II to IV and were referred to the emergency unit, medical wards and the cardiology out-patient clinic of our hospital. Heart failure was diagnosed using the Framingham criteria.
We excluded patients with a known history of co-existing conditions that can cause PH, besides left heart disease. These included patients with sickle cell disease, chronic parenchymal lung disease, human immunodeficiency virus infection, chronic liver disease with portal hypertension, congenital heart disease, obstructive sleep apnoea, chronic kidney disease, chronic exposure to high altitude, and use of anorexigenic agents.
Approval for this study was obtained from the Health Research and Ethics Committee of the Lagos University Teaching Hospital. Subjects were duly counselled about the aims and objectives of the study. Written informed consent was obtained prior to recruitment.
The bio-data of the subjects were obtained. A history was taken and physical examination performed to ascertain the diagnosis and aetiology of HF, to determine the patient's functional class and duration of illness, measure various anthropometric indices, and screen for the exclusion criteria mentioned above.
Transthoracic echocardiography was done with a Sonoscape SSI-8000 machine and 3.5-MHz transducer probe. Two-dimensional (2D) directed M-mode and Doppler transthoracic echocardiography were performed in the parasternal, apical and subcostal views on all 219 subjects.
The 2D directed M-mode measurements were done in accordance with recommendations of the American Society of Echocardiography (ASE) to determine LV chamber dimensions and LV ejection fraction (LVEF). Right ventricular (RV) longitudinal systolic function was assessed by the tricuspid annular plane systolic excursion (TAPSE).
10 2D parameters of RV structure were also assessed. These included RV basal diameter, right atrial area, RV wall thickness and eccentricity index. 11 Doppler echocardiography was performed to determine pulmonary artery systolic pressure (PASP), LV diastolic function and the severity of MR.
PASP was determined by the tricuspid regurgitant (TR) jet method, using the ASE guidelines for assessment of the right heart. 11 The peak TR jet velocity (V) was measured by colour Doppler guided continuous-wave Doppler in the apical fourchamber view, parasternal RV inflow view and parasternal shortaxis view at aortic valve level. The highest velocity obtained from any of these views was selected.
Right atrial pressure (RAP) was estimated from the size and collapsibility of the inferior vena cava (IVC) by assigning standardised values, recommended by the guidelines. 11 The estimated PASP was then calculated using the modified Bernoulli equation: PASP = 4V 2 + RAP A cut-off value of PASP > 36 mmHg, suggesting PH, was employed in this study, based on the 2009 European Society of Cardiology (ESC) 8 and 2010 ASE 11 recommendations. These were the prevailing guidelines during the planning and execution of this study.
LV diastolic function was assessed according to the ASE guidelines, 12 using transmitral Doppler velocities, left atrial volume index, and tissue Doppler of the septal and lateral mitral annulus. All Doppler measurements were taken at the end of expiration, using the average of measurements obtained during three consecutive cardiac cycles.
LV filling pressure was assessed using the E/e′ ratio (ratio of the pulsed-wave transmitral E velocity and average tissue Doppler e′ velocities). Diastolic dysfunction was graded as normal, grade 1 (impaired LV relaxation), grade 2 (pseudonormal filling pattern with mild elevation in LV filling pressure) or grade 3 (restrictive LV filling pattern and marked elevation in LV filling pressure).
Severity of MR was assessed by calculating the mitral regurgitant volume (MRvol) using the formula: MRvol = SV mitral -SV LV outflow tract 13 where SV mitral is the mitral valve stroke volume and SV LV outflow tract is the LV outflow tract stroke volume. MR severity was graded according to the ASE guidelines 13 as follows: mild (< 30 ml), moderate (30-60 ml) and severe (> 60 ml).
Statistical analysis
Data were analysed using the Statistical Package for Social Sciences version 17.0 (SPSS, Inc, Chicago, IL, USA). Normally distributed numerical data are presented as means and standard deviations, while the skewed ones are expressed as medians and ranges. Categorical variables are presented as proportions.
Means were compared using the Student's t-test. Categorical variables were compared using the chi-squared test or Fisher's exact test when cell counts were less than five. Correlation analyses were done to demonstrate associations between pulmonary pressures and specific clinical and echocardiograhic parameters. Pearson's correlation was done for normally distributed variables while Spearman's rank correlation was used for variables that did not meet normality assumptions. Forward stepwise multiple linear regression analyses were performed in order to determine the clinical and echocardiographic parameters that were independently associated with PASP in the study population.
Results
A total of 219 subjects with heart failure were recruited for this study, comprising 132 males (60.3%) and 87 females (39.7%). Mean age of the study population was 56 ± 15 years. Other clinical characteristics of the study population are summarised in Table 1 . The most common aetiology of HF in the overall study population was hypertensive heart disease, which was found in 107 (48.9%) subjects, followed by idiopathic dilated cardiomyopathy, which occurred in 74 (33.8%) subjects. One hundred and forty-six subjects (66.7%) had heart failure with reduced ejection fraction (HFrEF), while 73 (33.3%) had heart failure with preserved ejection fraction (HFpEF). The frequency of PH using an estimated PASP cut-off value of > 36 mmHg was present in 85 (38.8%) subjects.
Clinical characteristics of HF subjects with and without PH are summarised in Table 2 . HF subjects with PH tended to be male (p = 0.03) with a lower body mass index (BMI) (p = 0.002) and higher NYHA functional class (p < 0.001) compared with those without PH. However, there was no significant difference in the frequency of previous hospitalisations (p = 0.74) and duration of HF (p = 0.26) between the groups. The presence of PH was significantly associated with a HF aetiology of dilated cardiomyopathy (p = 0.02) and valvular heart disease (p = 0.015), while the absence of PH was associated with hypertensive heart disease (p = 0.008) ( Table 3) .
Comparison of the echocardiographic characteristics of HF subjects with and without PH is summarised in Table 4 . HF subjects with PH had significantly higher left atrial and LV chamber dimensions (p < 0.001). They also had poorer LV systolic function, higher LV diastolic dysfunction grade ( Fig. 1) and LV filling pressures, assessed by E/e′ ratio (p < 0.001 for all). The presence of PH was associated with more severe MR (Fig. 2) . The subjects with PH had significantly worse parameters of right heart structure and function, compared with the non-PH group.
The age and BMI of the study population correlated negatively with PASP (p = 0.02, p < 0.001, respectively). The pulse of the subjects had a significant but weak positive correlation with PASP (r = 0.138, p = 0.04). Other clinical parameters did not show significant correlations with PASP (Table 5) . PASP correlated significantly with all selected echocardiographic parameters of left heart structure and function, such as left atrial volume index (LAVI), LV mass index, LVEF and E/e′ ratio ( Table 5 ). The mitral regurgitant volume correlated positively with PASP (r = 0.269, p < 0.001). All parameters of RV structure and function correlated significantly with PASP.
Multivariate analyses were performed in order to determine the clinical and echocardiographic parameters that were independently associated with PASP in the study population (Table 6) . A model was derived by forward stepwise multiple linear regression analysis with PASP as the dependent variable. The independent/predictor variables included in the analysis were relevant clinical and left heart echocardiographic parameters with statistically significant correlations on univariate analysis with p-values < 0.05. These were age, gender, pulse rate, BMI, LAVI, LV mass, LVEF, E/e′ ratio and mitral regurgitant volume. Right heart echo parameters were not included in the models because they can be deranged as a consequence of PH and therefore are not predisposing factors. The analysis revealed that only LAVI and E/e′ ratio were independently associated with PASP.
Discussion
This study showed that pulmonary hypertension was fairly common among the HF subjects and was significantly associated with clinical and echo indices of worsening HF severity. The frequency of PH varies widely in the literature, with a reported range of 7-83%. 1, 2, 5, [14] [15] [16] [17] [18] [19] [20] [21] [22] This is likely due to differences in assessment methods and cut-off values. We found a PH frequency of 38.8%, which is quite close to that of some studies 17, 18 that employed a similar cut-off value but much lower than in two community studies 1,2 carried out in the USA. Our reported PH frequency is also lower than in two earlier local studies done in Nigeria by Karaye et al. 14 and Amadi et al., 22 reporting an occurrence of 66 and 70.4%, respectively. This was probably due to the differences in PH estimation methods employed.
The clinical characteristics of the HF subjects with and without PH were compared. Significant differences were noted with gender, BMI, pulse rate, systolic blood pressure and NYHA functional class. The PH group in this study had a significantly lower BMI than the non-PH group. This finding was also reported by some investigators, 2, 6 although other studies 1, 5 did not find any significant difference. A lower BMI in HF has been associated with increased disease severity and higher mortality risk, most likely due to the effects of TNF-alpha and catecholamine excess, which lead to cachexia and depressed LV function. 23, 24 Therefore HF patients with a lower BMI are likely to have poorer LV function and higher LV filling pressures, which are associated with elevated PASP. This finding differs from what is described in the normal population, where subjects with higher BMI have slightly higher PASP. 25 In this study, a significantly higher proportion of the HF subjects with PH were in NYHA class III and IV, compared with the non-PH subgroup. This suggests that PH in HF patients is associated with worsening HF severity, which has also been reported by other studies. 2, 5 This is an expected finding, bearing in mind that decompensated HF patients usually present with an increased level of pulmonary venous congestion as a result of higher LV filling pressures. 3, 4, 26, 27 A comparison of HF aetiologies between subjects with and without PH was done in this study. Significant differences were observed in the occurrence of hypertensive heart disease, idiopathic dilated cardiomyopathy (DCM), and valvular heart disease (VHD). The PH group had a significantly lower frequency of hypertensive heart disease (37.6%) compared with the non-PH group (56%). This was also reported among hospitalised HF patients in a study done in northern Nigeria.
14 In our study, PH was associated with a HF aetiology of DCM and VHD. Amadi et al. 22 found a similar association between PH and DCM among HF subjects in south-western Nigeria. However, in a similar study, Karaye et al.
14 did not find a significant association between PH and both HF aetiologies, perhaps due to the smaller sample of 80 patients enrolled in their study. The frequency of subjects with a DCM echo pattern was also significantly higher in the PH group compared with the non-PH group. The higher frequency of DCM or a DCM echo morphology observed in PH subjects might have been due to the restrictive diastolic physiology associated with high LV filling pressures commonly seen in these patients. 28 Among our HF population, we did not find an independent relationship between clinical parameters and PASP. This was also reported in a similar study among a mixed HF population. 5 The key echocardiographic factors implicated in the development of PH in HF patients are left heart variables associated with increased pulmonary venous pressure. 4 These factors include markers of elevated LV filling pressure and parameters of MR, as demonstrated by most studies. 1, 2, [5] [6] [7] This has been further confirmed in the present study in which echocardiographic markers of elevated LV filling pressures and diastolic function, LAVI and E/e′ ratio correlated significantly and positively with PASP on both univariate and multivariate analyses. This suggests that worsening LV diastolic function and increasing LV filling pressures are independently associated with increasing PASP.
Mitral regurgitant volume correlated positively with PASP. This suggests that worsening MR in the study population was associated with increasing pulmonary artery pressures. However, this finding was not significant on multivariate analysis. Chronic mitral regurgitation results in maladaptive increases in LV dimension, increase in systolic wall stress, progressive decline in LV contractile function, elevation of left atrial pressure, and therefore worsening PH. 29 The relationship between LVEF and PH is less clear in view of the conflicting data reported in various studies. 1, 2, 5, 6, 14, 30 In this study, LVEF correlated negatively with PASP. This suggests that worsening LV systolic function was associated with increasing PASP. The association of worsening LVEF and PH is likely to be seen in studies of isolated or predominant HFrEF populations. 5, 6, 30 The present study had a predominant HFrEF frequency of 66.7%. Other studies 5, 6 that did not find a significant association had isolated or a significant number of HFpEF subjects.
PH of any cause is associated with compensatory and maladaptive changes of the right heart. 4, 31 In this study, all the parameters of RV structure (RV basal and RV wall thickness dimensions) and function (TAPSE and eccentricity index) correlated significantly with PASP. This finding highlights the importance of properly assessing the right side of the heart, which can help to characterise patients with borderline Dopplerderived pulmonary artery pressure measurements.
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Conclusion
PH is a fairly common condition among HF subjects, occurring in over a third of this study. Its presence in our HF population was significantly associated with higher LV filling pressures, more severe MR, poorer LV systolic function and worse RV remodelling. Echocardiographic screening for pulmonary hypertension should be done in all HF patients in order to identify those at high risk who require aggressive optimisation of standard therapy, as recommended by guidelines.
